Onyx bidding war boosts execs' potential pay
July 01, 2013 at 02:02 AM EDT
A buyout of Onyx Pharmaceuticals Inc. — whether by Amgen Inc. or another company — could gross Chairman and CEO Tony Coles and three top deputies a total of $50 million or more...
